Understanding why patients stop buprenorphine treatment early
Predictors and Processes of Early Buprenorphine Discontinuation
This study is looking into why some people stop taking buprenorphine for opioid addiction too soon, focusing on different factors like who they are, their doctors, and any challenges they face in getting care, to help find ways to keep more people in treatment longer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Portland VA Medical Center NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10989884 on NIH RePORTER |
What this research studies
This research investigates the reasons behind the early discontinuation of buprenorphine treatment for opioid use disorder. It aims to explore various factors that may contribute to this issue, including patient demographics, provider influences, and systemic barriers to care. By gathering data from a diverse group of patients, including those from rural areas and underrepresented communities, the study seeks to identify key predictors and processes that lead to early treatment cessation. The findings could help improve treatment retention and outcomes for individuals struggling with opioid addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals currently receiving buprenorphine treatment for opioid use disorder, particularly those who may be at risk of discontinuation.
Not a fit: Patients who are not currently undergoing buprenorphine treatment or those with other forms of addiction treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for keeping patients engaged in buprenorphine treatment, ultimately reducing the risks associated with early discontinuation.
How similar studies have performed: While some prior research has identified predictors of treatment discontinuation, this study's comprehensive approach and focus on patient perspectives represent a novel exploration in this area.
Where this research is happening
Portland, United States
- Portland VA Medical Center — Portland, United States (Active)
Researchers
- Principal investigator: Wyse, Jessica Jasmine — Portland VA Medical Center
- Study coordinator: Wyse, Jessica Jasmine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.